This site is intended for healthcare professionals only
LoginRegister
JnJ receives USFDA Approval for updated Varipulse Platform Irrigation RateUSFDA expands indication for Impella Heart Pumps to treat Pediatric patients: Johnson & Johnson...
Gilead Sciences ropes in Sanofi official Dietmar Berger as new Chief Medical OfficerGilead Sciences ropes in Sanofi official Dietmar Berger as new Chief Medical Officer
USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoidUSFDA grants Breakthrough Therapy designation to Sanofi tolebrutinib for non-relapsing secondary...
Biocon Chief Kiran Mazumdar Shaw condoles former Karnataka CM S M Krishna deathBiocon Chief Kiran Mazumdar Shaw condoles former Karnataka CM S M Krishna death
11 years after acid attack, doctor’s friend jailed for 12 YearsDrug controller gets 3-year jail, Rs 7L fine for amassing illicit wealth including silver artefacts,...
Biocon sells 80 lacs equity shares of Syngene InternationalBiocon sells 80 lacs equity shares of Syngene International for Rs 686 crores
Jan Aushadhi KendrasPharmaceuticals & Medical Devices Bureau of India, Cooperative sector to open Jan Aushadhi Kendras...
Cipla arm Medispray Goa facility classified as VAI by USFDADiabetes management: Cipla bags CDSCO regulatory nod for distribution, marketing of Afrezza (insulin...
Biocon Biologics expands biosimilar insulin portfolio with USFDA nod of KirstyBiocon Biologics recognized as Asia IP Elite for 2024 by IAM
Merck Animal Health gets USFDA nod for Bravecto Quantum to protect dogs from fleas, ticksUSFDA nod to Gland Pharma Vitamin K deficiency treatment drug
Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival in Patients With Advanced Epithelial Ovarian Cancer: MerckPhase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival in Patients With...
Delhi HC Orders Arbitration in Medikabazaar Board Dispute, Tiwari Challenges TerminationCardiocontin vs. Nitrocontin: Delhi HC Warns of Life-Threatening Confusion Over Pharma Trademarks
X